Does the interplay between human endogenous retrovirus K and extracellular vesicles contribute to aging?
1Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892, USA.
2Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA.
#Authors contributed equally.
Correspondence to: Catherine DeMarino, Ph.D, Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, Building 10; Room 7C101, 10 Center Drive, Bethesda, MD 20892, USA. E-mail:
The role of extracellular vesicles (EVs), including retroviral-like particles (RVLPs), in pathogenic processes is currently a subject of active investigation. Several studies have identified mechanistic links between the increased presence of EVs and the process of senescence. A recent study reveals that the reverse transcribed complementary DNA (cDNA) of a human endogenous retroviral sequence can activate the innate immune system and result in tissue damage and/or the spread of cellular senescence to distant tissues. Several studies have linked EVs to age-related diseases, such as Alzheimer’s disease and Parkinson’s disease, and have included isolation of EVs from individuals with these diseases. Loss of epigenetic regulation, immune activation, and environmental stimuli can all lead to the expression of endogenous retroviruses and the incorporation of their proteins and transcripts into EVs. In addition, EVs disseminating these endogenous retroviral components have now been shown to act in a paracrine manner in multiple human diseases. Further investigation of the connection between EVs containing endogenous retroviral protein products or nucleotides should be pursued in models of age-related diseases.
Aging is a process that encompasses physical decline and a higher susceptibility to chronic diseases. The molecular mechanisms underlying it are an area of active scientific inquiry. Recently, there has been a burgeoning interest in exploring the involvement of transposable elements (TEs) in age-related diseases and senescence. Endogenous retroviruses, a type of TE, expand their presence in the genome through a "copy and paste" mechanism involving their transcription, protein expression, and subsequent reverse transcription of their RNA intermediate back into a new location in the genome. Several TE classes have been implicated in aging, including retrotransposons both with and without long terminal repeats (LTRs), such as long interspersed elements (LINEs) and endogenous retroviruses (ERVs)[2-4]. TEs are passed down in a Mendelian fashion following their integration into the germline and approximately 8% of the human genome is comprised of ERV sequences[5-8]. The most recently integrated endogenous retrovirus in the human genome is the Human Endogenous Retrovirus K (HERV-K, sub-type HML-2), which contains multiple open reading frames for viral proteins, such as Gag, Reverse Transcriptase (RT), Envelope (Env), and Protease (Pro)[7-9].
REGULATION OF ENDOGENOUS RETROVIRUSES
Endogenous retroviral expression is normally tightly spatially and temporally controlled by multiple epigenetic mechanisms, including methylation and heterochromatin facilitated by chromatin remodeling[10-14]. There are some endogenous retroviral proteins that play a role in normal physiology, such as the Arc protein, a repurposed retrotransposon Gag gene that mediates the process of intercellular transfer of RNA. Early in human development, human endogenous retrovirus promoters are hypomethylated combined with open chromatin, allowing these elements to be expressed; further, their expression appears to be necessary for normal development to proceed. In addition, human endogenous retrovirus W produces envelope proteins that are essential for syncytia formation and development of the placenta during pregnancy[16-18]. Many Env proteins also contain immunosuppressive domains, which have been co-opted during placental development to protect the developing fetus and can potentially contribute to cancer cells’ evasion of the immune system[17-20]. Disruption of envelope expression during placental formation can lead to pathologies caused by disrupted cell fusion and has been observed in cytotrophoblasts, fetuses, and placentas with trisomy 21, gestational diabetes, and preeclampsia[21-25]. In early development, even though higher expression of endogenous retroviral elements is critical, it is essential to ensure their proper downregulation as development progresses to prevent pathological consequences. Endogenous retroviruses are downregulated via methylation and chromatin remodeling as development progresses, and the transcription and subsequent translation of their proteins are often observed in pathological conditions,
Endogenous retrovirus transcripts and proteins can be exported in extracellular vesicles (EVs), including retroviral like particles (RVLPs), from cells and operate as a paracrine signaling mechanism which cells use to signal for continued pluripotency and proliferation[4,10,15,28,29]. Extracellular vesicles are defined as secreted bilayer lipid membrane-enclosed particles that can derive from nearly any cell type, including neurons, and their role in physiology and pathogenesis is an area of recent scientific interest[30,31]. Further, this phenomenon has also been observed in the placenta[28,32]. Extracellular vesicles containing endogenous retroviral nucleic acids and proteins have been implicated in the pathogenesis of various conditions, particularly in age-related diseases[4,27]. Furthermore, a recent publication revealed the reactivation of endogenous retroviral expression could act as a biomarker and even a driver of aging using multiple cross-species models of premature aging phenotypes. In this context, EVs containing HERV-K proteins in one tissue could act via paracrine signaling and result in inflammation and damage in other tissues, akin to the senescence-associated secretory phenotype (SASP) and its role in aging[33,34]. This study reveals a role for EVs containing endogenous retroviral proteins and provides evidence that their uptake by recipient cells can lead to aging-associated phenotypes while also showing that these effects can be prevented through therapeutic strategies.
The aging process occurs over time as cells become senescent and molecular mechanisms that support the process of self-renewal decline. Stingent control of chromatin remodeling and the maintenance of epigenetic mechanisms that control gene expression tend to decrease after an organism reaches its peak reproduction age, allowing the expression of transcripts, such as HML-2, that are typically supressed at earlier time points. In addition to epigenetic regulation, several transcription factors associated with the innate immune response, including NF-κB, IRF-1, IRF-3, and IRF-7, have the potential to activate the endogenous retrovirus LTR, suggesting that any number of immune stimulants (viruses, bacteria, cell damage derivatives) and environmental factors could contribute to premature aging-related phenotypes[Figure 1]. Given the many transcription factor binding sites present in ERV promoters, their activation could contribute to immunosenescence and inflammaging, defined as a state of continued antigenic load and the subsequent stress response that leads to aging, which has been associated with pandemic viruses such as Human Immunodeficiency Virus (HIV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)[38-42]. In fact, ERVs may be a link between infections and the acceleration of aging-related degenerative diseases.
Figure 1. Illustration depicting the expression of an endogenous retrovirus, HERV-K HML-2, and its role in the spreading of a senescent phenotype in vitro. The diagram illustrates HML-2 expression from the Chr7p22.1a locus, which is stimulated by the binding of transcription factors IRF-1 and NF-κB as a result of innate immune activation or environmental factors. HML-2 transcription and translation of HML-2 open reading frames (ORFs) and the subsequent packaging of its transcripts and proteins into an extracellular vesicle are depicted. The extracellular vesicles produced by senescent cells are then able to act in a paracrine manner and can be endocytosed by a recipient cell, resulting in the spreading of an aging or senescent phenotype (as indicated by the yellow arrow).
In a recent study, several models of cellular senescence were used to explore a potential role for endogenous retroviral-like particles and EVs containing their proteins in both normal aging and in diseases with premature aging phenotypes, such as Hutchinson-Gilford progeria syndrome (HGPS) and in Werner syndrome (WS). Human mesenchymal progenitor cells (hMPCs) were used throughout the study to establish in vitro effects of cellular senescence caused by the expression of HERV-K, a human-specific TE that is normally silenced in mature tissues[4,11]. As has been observed in other studies, HERV-K reactivation or "resurrection" is shown to be caused by reduced DNA methylation of its promoters as well as open chromatin in aged cells like those derived from individuals with HGPS or WS[4,11]. These models presented a premature aging phenotype, including increased β-galactosidase-positive cells, decreased cellular proliferation, and reduced clonal expansion ability. Electron microscopy of wild-type, HGPS, and WS hMPCs in combination with western blotting of their conditioned medium (cm) displayed EVs containing endogenous retroviral proteins that were significantly more highly expressed in HGPS and WS cells. In the same study, using quantitative polymerase chain reactions (qPCR), ribonucleic acid fluorescence in situ hybridization (RNA-FISH), and single molecule RNA-FISH (smRNA-FISH), the authors were able to establish that the expression of HERV-K elements in these senescent cells was initiated by transcription at their promoter due to reduced CpG methylation and decreased repressive histone marks. In addition, EVs expressing the HERV-K envelope proteins were observed rarely in early passage hMPCs but were more common in cells with increased markers of senescence, and in primary human fibroblasts isolated from older individuals.
To establish that the senescent phenotypes were directly related to HERV-K expression, a CRISPR-Cas9 activation system was used to upregulate HERV-K element expression in hMPCs and resulted in an increase in senescent features which was reversible with the targeted downregulation of HERV-K transcription. Young hMPCs were incubated with EVs isolated from replicative senescent (RS) cells, as well as cells derived from individuals with HGPS and WS, which resulted in decreased proliferation, increased expression of β-galactosidase, and additional senescent phenotypes. When the culture medium containing the EVs was immunodepleted with anti-HERV-K antibodies, the senescent effects of the EVs were attenuated on the treated young hMPCs. These data suggested that EVs containing HERV-K transcripts and proteins can act in a paracrine manner and trigger senescent phenotypes in previously non-senescent or young cells [Figure 1].
Multiple HML-2 HERV-K loci in the human genome encode open reading frames for viral proteins such as Gag, RT, Pro, and Env; in addition, elements that encode these proteins are expressed in both normal and diseased tissues[10,43-45]. The HERV-K Pol gene encodes a protein that acts as a reverse transcriptase and reverses transcribes RNA into DNA[46-49]. As a result of Pol activity, HERV-K DNA increased in the cytoplasm of the senescent hMPCs, which led the authors to investigate whether this DNA could be detected by the DNA sensor cGMP-AMP synthase (cGAS), thereby triggering innate immune system activation[50-52]. Using immunoprecipitation, the authors observed increased expression of cGAS in senescent (late passage) hMPCs as compared with early passage hMPCs. Increased phosphorylation of TANK-binding kinase 1 (TBK1), RelA, and interferon (IFN) regulatory factor 3 (IRF3) were also detected, further supporting the activation of the cGAS pathway. Interestingly, both the activation of cGas and senescence-associated phenotypes were abrogated following the treatment of senescent hMPCs with Abacavir, an inhibitor of reverse transcriptase. Taken together, these data emphasize that the expression of a full-length HERV-K provirus is not necessary for significant effects on downstream signaling.
There are only nine HERV-K loci in the human genome that can encode full-length RT; however, only three of these loci also contain functional GAG and Pro ORFs and are likely to result in functional protein [Table 1], and these loci are expressed in some normal tissues. When HERV-K RNA or cDNA is packaged into extracellular vesicles, it may avoid detection by the immune system. Extracellular vesicles may be exported from senescent cells, then imported into more distal cells or other tissues and thereby evade the immune system as previously described. This phenomenon has been observed for many viruses, including JC polyomavirus, herpes simplex virus 1, hepatitis E virus, hepatitis C virus, and enterovirus 71. Therefore, it is critical to understand the role of these extracellular vesicles in a disease context, as they can not only disseminate HERV-K products to distant tissues, potentially in a cell-type specific manner, but they can also simultaneously enable immune evasion.
HML-2 HERV-K loci with open reading frames for reverse transcriptase
|Strand||Type||Host gene||Expression mode||
# of Tissues
STUDY LIMITATIONS AND FUTURE DIRECTIONS
To date, no study has determined how the expression of HERV-K contributes to the senescence of brain cells. Further, transcription analysis has not revealed from which loci the HERV-K transcripts originate, which may be key in understanding their activation. Currently, most studies use short-read sequencing, which makes it difficult to predict which loci are producing HERV-K sequences due to the repetitive nature of their sequence. Long-read sequencing should be performed on transcripts isolated from extracellular vesicles produced by senescent cells to determine which HERV-K loci or other transposable elements may play a role in pathology.
Considering the recent developments regarding extracellular vesicles in models of aging, this area should be further investigated in additional advanced aging models such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). In fact, extracellular vesicles have been isolated from individuals with AD, ALS, and PD[55-57]. Extracellular vesicles have been isolated from blood in individuals with motor neuron disease and there was a significant increase in the level of the HERV-K envelope protein in individuals with advanced disease compared to those in an earlier phase of the disease. In a recent study, when mice were treated with extracellular vesicles isolated from brain lysates and cerebrospinal fluid (CSF) of individuals with PD, they displayed multiple symptoms consistent with PD, such as motor behavior impairment and high anxiety. In AD, a significant increase in endogenous retrovirus expression was observed and associated with heterochromatin decondensation and depletion of piwi and piRNAs, which normally act to silence their expression. In a recent study, extracellular vesicles containing either HERV-K HML-2 Env or HERV-W Env (Syncytin-1) were shown to increase protein aggregates in vitro, suggesting their expression in diseases like AD could contribute to Tau aggregation. These findings suggest that the presence of endogenous retroviral envelope proteins could be used as a biomarker for several age-related neurodegenerative diseases, and this should be further explored in studies with larger numbers of individuals.
Transcripts, proteins, and reverse transcribed cDNAs originating from TEs are often packaged into extracellular vesicles[10,13,59,60]. The extracellular vesicles can act as a conduit to spread the TE products throughout the body to other tissues in a paracrine manner and lead to potentially negative consequences in distal tissues. It follows that activation of ERV in one tissue as a result of epigenetic de-repression or stimuli-driven transcription has the potential to impact the entire body despite a tissue-specific origin. In future studies, the contents of extracellular vesicles released in vitro from senescent cells should be evaluated with both transcriptomics and proteomics to further characterize which components, in addition to endogenous retroviral transcripts and proteins, could contribute to the phenotype(s) of the recipient cells. Further, liposomes containing only endogenous retroviral proteins and transcripts should be tested in animal models to determine whether they are sufficient to cause a senescent phenotype in vivo.
We and others have shown that loss of function of chromatin remodeling proteins in developmental tumors, e.g., Atypical Teratoid Rhabdoid Tumor (AT/RT), leads to the expression of endogenous retroviral elements[10,62]. AT/RT has a bimodal distribution of disease in both young and older individuals, highlighting the possibility of endogenous retroviral involvement in tumors occurring later in life. A key epigenetic regulator, the chromatin remodeling SWItch/Sucrose Non-Fermentable (SWI/SNF) complex, plays an important role in the transcriptional activation of stress-response genes that are often activated during aging. In addition, the expression of endogenous retroviruses is tightly spatially and temporally regulated during development, and they are normally downregulated as cells differentiate and mature[11,64]. Therefore, endogenous retroviral expression may be an excellent treatment target for neurodevelopmental tumors, neurodegenerative diseases, and senescence, and current treatments, e.g., anti-retroviral drugs and ERV targeting short hairpin RNAs (shRNAs), designed to abrogate their expression should potentially be explored[10,26,65]. Recent work in the field, the plethora of tumors with chromatin remodeling defects and ERV involvement, and the noted role of ERVs in other age-related diseases suggest further investigation is needed to understand the interplay between extracellular vesicles, endogenous retroviruses, and aging-related pathologies.
Made substantial contributions to the conception and design of the study and performed data analysis and interpretation: Doucet-O’Hare TT, DeMarino C
Assisted in writing and reviewing manuscript: Nath A, Zhuang ZAvailability of data and materials
Not applicable.Financial support and sponsorship
This work was funded in part by the Intramural Program of NINDS and NCI at the NIH (ZIABC011773).Conflicts of interest
All authors declared that there are no conflicts of interest.Ethical approval and consent to participate.
Not applicable.Consent for publication
© The Author(s) 2023.
1. Luan DD, Korman MH, Jakubczak JL, Eickbush TH. Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: a mechanism for non-LTR retrotransposition. Cell 1993;72:595-605.
2. De Cecco M, Ito T, Petrashen AP, et al. L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature 2019;566:73-8.
3. Della Valle F, Reddy P, Yamamoto M, et al. LINE-1 RNA causes heterochromatin erosion and is a target for amelioration of senescent phenotypes in progeroid syndromes. Sci Transl Med 2022;14:eabl6057.
4. Liu X, Liu Z, Wu Z, et al. Resurrection of endogenous retroviruses during aging reinforces senescence. Cell 2023;186:287-304.e26.
5. Johnson WE. Origins and evolutionary consequences of ancient endogenous retroviruses. Nat Rev Microbiol 2019;17:355-70.
6. Blikstad V, Benachenhou F, Sperber GO, Blomberg J. Evolution of human endogenous retroviral sequences: a conceptual account. Cell Mol Life Sci 2008;65:3348-65.
7. Marchi E, Kanapin A, Magiorkinis G, Belshaw R. Unfixed endogenous retroviral insertions in the human population. J Virol 2014;88:9529-37.
8. Subramanian RP, Wildschutte JH, Russo C, Coffin JM. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology 2011;8:90.
9. Stoye JP. Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat Rev Microbiol 2012;10:395-406.
10. Doucet-O'Hare TT, DiSanza BL, DeMarino C, et al. SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression. Sci Rep 2021;11:12893.
11. Wang T, Medynets M, Johnson KR, et al. Regulation of stem cell function and neuronal differentiation by HERV-K via mTOR pathway. Proc Natl Acad Sci U S A 2020;117:17842-53.
12. Steiner JP, Bachani M, Malik N, et al. Human endogenous retrovirus k envelope in spinal fluid of amyotrophic lateral sclerosis is toxic. Ann Neurol 2022;92:545-61.
13. Shah AH, Rivas SR, Doucet-O'Hare TT, et al. Human endogenous retrovirus K contributes to a stem cell niche in glioblastoma. J Clin Invest 2023;133:e167929.
14. Grow EJ, Flynn RA, Chavez SL, et al. Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells. Nature 2015;522:221-5.
15. Pastuzyn ED, Day CE, Kearns RB, et al. The neuronal gene arc encodes a repurposed retrotransposon gag protein that mediates intercellular RNA transfer. Cell 2018;172:275-88.e18.
16. Frendo JL, Olivier D, Cheynet V, et al. Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol Cell Biol 2003;23:3566-74.
17. Mangeney M, Renard M, Schlecht-Louf G, et al. Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Natl Acad Sci U S A 2007;104:20534-9.
18. Knerr I, Huppertz B, Weigel C, et al. Endogenous retroviral syncytin: compilation of experimental research on syncytin and its possible role in normal and disturbed human placentogenesis. Mol Hum Reprod 2004;10:581-8.
19. Bolze P, Mommert M, Mallet F. Contribution of syncytins and other endogenous retroviral envelopes to human placenta pathologies. Prog Mol Biol Transl Sci 2017;145:111-62.
20. Cornelis G, Vernochet C, Carradec Q, et al. Retroviral envelope gene captures and syncytin exaptation for placentation in marsupials. Proc Natl Acad Sci U S A 2015;112:E487-96.
21. Frendo JL, Vidaud M, Guibourdenche J, et al. Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down's syndrome. J Clin Endocrinol Metab 2000;85:3700-7.
22. Massin N, Frendo JL, Guibourdenche J, et al. Defect of syncytiotrophoblast formation and human chorionic gonadotropin expression in Down's syndrome. Placenta 2001;22 Suppl A:S93-7.
23. Vargas A, Toufaily C, LeBellego F, Rassart E, Lafond J, Barbeau B. Reduced expression of both syncytin 1 and syncytin 2 correlates with severity of preeclampsia. Reprod Sci 2011;18:1085-91.
24. Lee X, Keith JC Jr, Stumm N, et al. Downregulation of placental syncytin expression and abnormal protein localization in pre-eclampsia. Placenta 2001;22:808-12.
25. Soygur B, Sati L, Demir R. Altered expression of human endogenous retroviruses syncytin-1, syncytin-2 and their receptors in human normal and gestational diabetic placenta. Histol Histopathol 2016;31:1037-47.
26. Shah AH, Govindarajan V, Doucet-O'Hare TT, et al. Differential expression of an endogenous retroviral element [HERV-K(HML-6)] is associated with reduced survival in glioblastoma patients. Sci Rep 2022;12:6902.
27. Liu S, Heumuller SE, Hossinger A, et al. Reactivated endogenous retroviruses promote protein aggregate spreading. Nat Commun 2023;14:5034.
28. Vargas A, Zhou S, Éthier-Chiasson M, et al. Syncytin proteins incorporated in placenta exosomes are important for cell uptake and show variation in abundance in serum exosomes from patients with preeclampsia. FASEB J 2014;28:3703-19.
29. Contreras-Galindo R, Kaplan MH, Dube D, et al. Human endogenous retrovirus type K (HERV-K) particles package and transmit HERV-K-related sequences. J Virol 2015;89:7187-201.
30. Lötvall J, Hill AF, Hochberg F, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the international society for extracellular vesicles. J Extracell Vesicles 2014;3:26913.
31. Li Y, Chen Y, Zhang N, Fan D. Human endogenous retrovirus K (HERV-K) env in neuronal extracellular vesicles: a new biomarker of motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener 2022;23:100-7.
32. Record M. Intercellular communication by exosomes in placenta: a possible role in cell fusion? Placenta 2014;35:297-302.
33. Ovadya Y, Landsberger T, Leins H, et al. Impaired immune surveillance accelerates accumulation of senescent cells and aging. Nat Commun 2018;9:5435.
34. Yin Y, Chen H, Wang Y, Zhang L, Wang X. Roles of extracellular vesicles in the aging microenvironment and age-related diseases. J Extracell Vesicles 2021;10:e12154.
35. Wood JG, Helfand SL. Chromatin structure and transposable elements in organismal aging. Front Genet 2013;4:274.
36. Manghera M, Douville RN. Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors? Retrovirology 2013;10:16.
37. Levine KS, Leonard HL, Blauwendraat C, et al. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron 2023;111:1086-93.e2.
38. Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000;908:244-54.
39. O'Carroll IP, Fan L, Kroupa T, et al. Structural mimicry drives HIV-1 Rev-mediated HERV-K expression. J Mol Biol 2020;432:166711.
40. Petrone V, Fanelli M, Giudice M, et al. Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity. Front Microbiol 2023;14:1155624.
41. Wang D, Gomes MT, Mo Y, et al. Human endogenous retrovirus, SARS-CoV-2, and HIV promote PAH via inflammation and growth stimulation. Int J Mol Sci 2023;24:7472.
42. Temerozo JR, Fintelman-Rodrigues N, Dos Santos MC, et al. Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology. Microbiome 2022;10:65.
43. Wildschutte JH, Williams ZH, Montesion M, Subramanian RP, Kidd JM, Coffin JM. Discovery of unfixed endogenous retrovirus insertions in diverse human populations. Proc Natl Acad Sci U S A 2016;113:E2326-34.
44. Burn A, Roy F, Freeman M, Coffin JM. Widespread expression of the ancient HERV-K (HML-2) provirus group in normal human tissues. PLoS Biol 2022;20:e3001826.
45. Büscher K, Hahn S, Hofmann M, et al. Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell lines. Melanoma Res 2006;16:223-34.
46. Temin HM, Mizutani S. Viral RNA-dependent DNA Polymerase: RNA-dependent DNA polymerase in virions of rous sarcoma virus. Nature 1970;226:1211-3.
47. Baltimore D. Viral RNA-dependent DNA Polymerase: RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 1970;226:1209-11.
48. Berkhout B, Jebbink M, Zsíros J. Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus. J Virol 1999;73:2365-75.
49. Ono M, Yasunaga T, Miyata T, Ushikubo H. Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J Virol 1986;60:589-98.
50. Cortopassi G, Liu Y. Genotypic selection of mitochondrial and oncogenic mutations in human tissue suggests mechanisms of age-related pathophysiology. Mutat Res 1995;338:151-9.
51. Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005;122:669-82.
52. Schoggins JW, MacDuff DA, Imanaka N, et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 2014;505:691-5.
53. Horn MD, MacLean AG. Extracellular vesicles as a means of viral immune evasion, CNS invasion, and glia-induced neurodegeneration. Front Cell Neurosci 2021;15:695899.
54. Kritsilis M, V Rizou S, Koutsoudaki PN, Evangelou K, Gorgoulis VG, Papadopoulos D. Ageing, cellular senescence and neurodegenerative disease. Int J Mol Sci 2018;19:2937.
55. Ruan Z, Pathak D, Venkatesan Kalavai S, et al. Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons. Brain 2021;144:288-309.
56. Herman S, Djaldetti R, Mollenhauer B, Offen D. CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology. Brain 2023;146:209-24.
57. Komurian-Pradel F, Paranhos-Baccala G, Bedin F, et al. Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles. Virology 1999;260:1-9.
58. Sun W, Samimi H, Gamez M, Zare H, Frost B. Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies. Nat Neurosci 2018;21:1038-48.
59. Hardy MP, Audemard É, Migneault F, et al. Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs. Sci Rep 2019;9:7203.
60. Bowers EC, Motta A, Knox K, McKay BS, Ramos KS. LINE-1 cargo and reverse transcriptase activity profiles in extracellular vesicles from lung cancer cells and human plasma. Int J Mol Sci 2022;23:3461.
61. Keswani RK, Pozdol IM, Pack DW. Design of hybrid lipid/retroviral-like particle gene delivery vectors. Mol Pharm 2013;10:1725-35.
62. Dang DD, Rosenblum JS, Shah AH, Zhuang Z, Doucet-O'Hare TT. Epigenetic regulation in primary CNS tumors: an opportunity to bridge old and new WHO classifications. Cancers 2023;15:2511.
63. Zhang J, Ohta T, Maruyama A, et al. BRG1 interacts with Nrf2 to selectively mediate HO-1 induction in response to oxidative stress. Mol Cell Biol 2006;26:7942-52.
64. Doucet-O'Hare TT, Rosenblum JS, Shah AH, Gilbert MR, Zhuang Z. Endogenous retroviral elements in human development and central nervous system embryonal tumors. J Pers Med 2021;11:1332.
Cite This Article
DeMarino C, Nath A, Zhuang Z, Doucet-O’Hare TT. Does the interplay between human endogenous retrovirus K and extracellular vesicles contribute to aging?. Extracell Vesicles Circ Nucleic Acids 2023;4:548-56. http://dx.doi.org/10.20517/evcna.2023.45
DeMarino C, Nath A, Zhuang Z, Doucet-O’Hare TT. Does the interplay between human endogenous retrovirus K and extracellular vesicles contribute to aging?. Extracellular Vesicles and Circulating Nucleic Acids. 2023; 4(4): 548-56. http://dx.doi.org/10.20517/evcna.2023.45
DeMarino, Catherine, Avindra Nath, Zhengping Zhuang, Tara T. Doucet-O’Hare. 2023. "Does the interplay between human endogenous retrovirus K and extracellular vesicles contribute to aging?" Extracellular Vesicles and Circulating Nucleic Acids. 4, no.4: 548-56. http://dx.doi.org/10.20517/evcna.2023.45
DeMarino, C.; Nath A.; Zhuang Z.; Doucet-O’Hare TT. Does the interplay between human endogenous retrovirus K and extracellular vesicles contribute to aging?. Extracell. Vesicles. Circ. Nucleic. Acids. 2023, 4, 548-56. http://dx.doi.org/10.20517/evcna.2023.45
Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any queries or need any help, please contact us at email@example.com.